Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence"
AJR Am J Roentgenol
.
2024 Mar 20.
doi: 10.2214/AJR.24.31168.
Online ahead of print.
Authors
Eduardo Thadeu de Oliveira Correia
1
,
Andrei S Purysko
2
,
Bruno Merz Paranhos
3
,
Jonathan E Shoag
4
5
6
7
,
Anwar R Padhani
8
,
Leonardo Kayat Bittencourt
1
4
Affiliations
1
Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States.
2
Department of Radiology, Abdominal Imaging Section, Cleveland Clinic, Cleveland, Ohio, United States.
3
Department of Radiology, Diagnosticos da America S.A, Rio de Janeiro, Brazil.
4
Case Western Reserve University, Cleveland, Ohio, United States.
5
Case Comprehensive Cancer Center, Cleveland, Ohio, United States.
6
Department of Urology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States.
7
Department of Urology, Weill Cornell Medicine, New York, New York, United States.
8
Paul Strickland Scanner Centre, Mount Vernon Hospital, Middlesex, United Kingdom.
PMID:
38506544
DOI:
10.2214/AJR.24.31168
No abstract available
Keywords:
diffusion magnetic resonance imaging; magnetic resonance imaging; prostatic neoplasms.